Discover
EVOK
Evoke Pharma, Inc.
11.00
2 x 7.90
2 x 14.06
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
11.00 -0.00 (0.00%)
| Ytd | 148.87% | |
| 1y | 139.65% |
10.98
day range
11.00
3.54
52 week range
14.04
| Open | 10.98 | Prev Close | 11.00 | Low | 10.98 | High | 11.00 | Mkt Cap | 7.37M |
| Vol | 47.10K | Avg Vol | 395.00K | EPS | -10.13 | P/E | N/A | Forward P/E | 10.33 |
| Beta | 0.35 | Short Ratio | 0.24 | Inst. Own | 17.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.97 | 200-d Avg | 5.60 | 1yr Est | 18.00 |
| Income Statement | |||
| Total Revenue | 4.28M | ||
| Revenues (USD) | 4.28M | ||
| Cost of Revenue | 101.98K | ||
| Gross Profit | 4.18M | ||
| Operating Expenses | 5.32M | ||
| Research and Development Expense | 5.32K | ||
| Selling, General and Administrative Expense | 5.31M | ||
| Operating Income | -1.14M | ||
| Interest Expense | 126.03K | ||
| Net Income | -1.16M | ||
| Net Income Common Stock | -1.16M | ||
| Net Income Common Stock (USD) | -1.16M | ||
| Consolidated Income | -1.16M | ||
| Earnings per Basic Share | -0.45 | ||
| Earnings per Basic Share (USD) | -0.45 | ||
| Earnings per Diluted Share | -0.45 | ||
| Earning Before Interest & Taxes (EBIT) | -1.03M | ||
| Earning Before Interest & Taxes (USD) | -1.03M | ||
| Weighted Average Shares | 2.56M | ||
| Weighted Average Shares Diluted | 2.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.58M | ||
| Cash and Equivalents (USD) | 11.58M | ||
| Trade and Non-Trade Receivables | 3.19M | ||
| Current Assets | 15.54M | ||
| Property, Plant & Equipment Net | 106.71K | ||
| Total Assets | 15.65M | ||
| Debt Current | 5.07M | ||
| Total Debt | 5.11M | ||
| Current Liabilities | 12.24M | ||
| Debt Non-Current | 46.38K | ||
| Total Liabilities | 12.29M | ||
| Accumulated Retained Earnings (Deficit) | -132.82M | ||
| Shareholders Equity | 3.36M | ||
| Shareholders Equity (USD) | 3.36M | ||
| Assets Non-Current | 113.03K | ||
| Total Debt (USD) | 5.11M | ||
| Inventory | 599.91K | ||
| Liabilities Non-Current | 46.38K | ||
| Trade and Non-Trade Payables | 3.92M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.15K | ||
| Net Cash Flow from Financing | 38.90K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -483.06K | ||
| Issuance (Purchase) of Equity Shares | 38.90K | ||
| Net Cash Flow from Operations | -521.96K | ||
| Share Based Compensation | 105.06K | ||